ACLX
Price
$66.34
Change
-$2.73 (-3.95%)
Updated
Jan 13, 03:51 PM (EDT)
Capitalization
3.74B
66 days until earnings call
APLS
Price
$28.38
Change
+$0.94 (+3.43%)
Updated
Jan 13, 03:52 PM (EDT)
Capitalization
3.41B
50 days until earnings call
Ad is loading...

ACLX vs APLS

Header iconACLX vs APLS Comparison
Open Charts ACLX vs APLSBanner chart's image
Arcellx
Price$66.34
Change-$2.73 (-3.95%)
Volume$301
Capitalization3.74B
Apellis Pharmaceuticals
Price$28.38
Change+$0.94 (+3.43%)
Volume$1.35K
Capitalization3.41B
ACLX vs APLS Comparison Chart
Loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
APLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACLX vs. APLS commentary
Jan 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACLX is a Hold and APLS is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Jan 13, 2025
Stock price -- (ACLX: $69.08 vs. APLS: $27.44)
Brand notoriety: ACLX and APLS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ACLX: 264% vs. APLS: 126%
Market capitalization -- ACLX: $3.74B vs. APLS: $3.41B
ACLX [@Biotechnology] is valued at $3.74B. APLS’s [@Biotechnology] market capitalization is $3.41B. The market cap for tickers in the [@Biotechnology] industry ranges from $387.55B to $0. The average market capitalization across the [@Biotechnology] industry is $2.41B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACLX’s FA Score shows that 0 FA rating(s) are green whileAPLS’s FA Score has 0 green FA rating(s).

  • ACLX’s FA Score: 0 green, 5 red.
  • APLS’s FA Score: 0 green, 5 red.
According to our system of comparison, ACLX is a better buy in the long-term than APLS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACLX’s TA Score shows that 4 TA indicator(s) are bullish while APLS’s TA Score has 2 bullish TA indicator(s).

  • ACLX’s TA Score: 4 bullish, 4 bearish.
  • APLS’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, ACLX is a better buy in the short-term than APLS.

Price Growth

ACLX (@Biotechnology) experienced а -12.70% price change this week, while APLS (@Biotechnology) price change was -17.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.26%. For the same industry, the average monthly price growth was -0.61%, and the average quarterly price growth was -4.84%.

Reported Earning Dates

ACLX is expected to report earnings on May 08, 2025.

APLS is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (-6.26% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACLX($3.74B) has a higher market cap than APLS($3.41B). ACLX YTD gains are higher at: -9.923 vs. APLS (-14.008). ACLX has higher annual earnings (EBITDA): -33.12M vs. APLS (-209.71M). ACLX has more cash in the bank: 574M vs. APLS (397M). ACLX has less debt than APLS: ACLX (65.3M) vs APLS (470M). APLS has higher revenues than ACLX: APLS (715M) vs ACLX (156M).
ACLXAPLSACLX / APLS
Capitalization3.74B3.41B109%
EBITDA-33.12M-209.71M16%
Gain YTD-9.923-14.00871%
P/E RatioN/AN/A-
Revenue156M715M22%
Total Cash574M397M145%
Total Debt65.3M470M14%
FUNDAMENTALS RATINGS
APLS: Fundamental Ratings
APLS
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ACLXAPLS
RSI
ODDS (%)
Bullish Trend 6 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 6 days ago
88%
Bearish Trend 6 days ago
86%
Momentum
ODDS (%)
Bearish Trend 6 days ago
68%
Bearish Trend 6 days ago
84%
MACD
ODDS (%)
Bearish Trend 6 days ago
88%
N/A
TrendWeek
ODDS (%)
Bearish Trend 6 days ago
75%
Bullish Trend 6 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 6 days ago
72%
Bearish Trend 6 days ago
83%
Advances
ODDS (%)
Bullish Trend 11 days ago
89%
Bullish Trend 7 days ago
85%
Declines
ODDS (%)
Bearish Trend 14 days ago
76%
Bearish Trend 15 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
82%
Bullish Trend 6 days ago
86%
Aroon
ODDS (%)
Bearish Trend 6 days ago
66%
Bearish Trend 6 days ago
83%
View a ticker or compare two or three
Ad is loading...
ACLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
APLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CLBEX34.10-0.33
-0.96%
American Funds American Balanced 529E
SCETX7.48-0.12
-1.58%
Virtus Ceredex Small-Cap Value Eq I
BRWBX23.61-0.40
-1.67%
MFS Blended Research Growth Eq B
FMGGX48.30-0.83
-1.69%
Franklin Small-Mid Cap Growth R6
BCSSX53.87-1.29
-2.34%
Brown Capital Mgmt Small Co Instl

ACLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACLX has been loosely correlated with DNLI. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ACLX jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACLX
1D Price
Change %
ACLX100%
-4.40%
DNLI - ACLX
49%
Loosely correlated
-10.12%
KYMR - ACLX
48%
Loosely correlated
-5.80%
RCKT - ACLX
47%
Loosely correlated
-5.51%
RCUS - ACLX
47%
Loosely correlated
-4.83%
BEAM - ACLX
46%
Loosely correlated
-1.53%
More

APLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, APLS has been loosely correlated with PGEN. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if APLS jumps, then PGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APLS
1D Price
Change %
APLS100%
-16.85%
PGEN - APLS
42%
Loosely correlated
-0.42%
CYTK - APLS
38%
Loosely correlated
-1.58%
ROIV - APLS
37%
Loosely correlated
-3.54%
VCEL - APLS
37%
Loosely correlated
-0.05%
ATAI - APLS
37%
Loosely correlated
-7.41%
More